Charles Robb
2017
In 2017, Charles Robb earned a total compensation of $1.8M as Chief Financial Officer and Secretary at Corcept Therapeutics.
Compensation breakdown
Bonus | $320,000 |
---|---|
Option Awards | $1,062,589 |
Salary | $397,929 |
Total | $1,780,518 |
Robb received $1.1M in option awards, accounting for 60% of the total pay in 2017.
Robb also received $320K in bonus and $397.9K in salary.
Rankings
In 2017, Charles Robb's compensation ranked 6,083rd out of 14,666 executives tracked by ExecPay. In other words, Robb earned more than 58.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,083 | 59th |
Manufacturing | 2,235 | 61st |
Chemicals And Allied Products | 705 | 66th |
Drugs | 543 | 69th |
Pharmaceutical Preparations | 427 | 68th |
Robb's colleagues
We found four more compensation records of executives who worked with Charles Robb at Corcept Therapeutics in 2017.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019